- Data suggests that Omicron sub-variants are more immune-resistant than the original Omicron strain, possibly making retooled vaccines outdated by the time they are available in the fall.
- Some experts believe the virus could evolve to be resistant to Paxlovid treatment.
- A CDC report says that more than 33% of adults recovering from COVID-19 still had problems one month to a year after being infected. A study suggested that long COVID symptoms are possible in vaccinated Americans.
- A study suggests faulty oxygen readings delayed COVID treatments for darker-skinned patients.
- The CDC has updated its website and many of its guidelines including: V-safe After Vaccination Health Checker; Staffing Resources; and Archive of COVID-19 Vaccination Data Updates.
Congress
- There is a possibility that Congress will not reach a COVID-19 funding deal until at least the fall due to Congressional gridlock.
White House and Federal Agencies
- The CDC announced they will stop collecting data on suspected COVID-19 cases.
Economy, Vaccines, Testing and Treatment
- The American Medical Association has announced a CPT Code for the COVID-19 vaccine in young children, setting the stage for the shot’s potential use.
- The BA.2.12.1 Omicron sub-variant is now the dominant variant in the United States.
- Data suggests that Omicron sub-variants are more immune-resistant than the original Omicron strain, possibly making retooled vaccines outdated by the time they are available in the fall.
- The White House has announced the first federal “test-to-treat” site in Rhode Island. The site offers vaccinations and allows Americans who test positive for the disease to receive medical evaluation and antiviral treatment immediately.
- CMS updated the public use file (PUF) that reports Medicare utilization and information from Medicare claims related to the administration of the COVID-19 vaccine. Between December 11, 2020 and March 31, 2022, Medicare payments for the administration of the COVID-19 vaccine were $2.5 billion.
- Some doctors are reconsidering Pfizer’s Paxlovid for lower-risk COVID patients.
- Some experts believe the virus could evolve to be resistant to Paxlovid treatment.
- The Justice Department asked a federal appeals court to overturn a court decision that declared the mask mandate on public transportation and airplanes unlawful.
- A CDC report says that more than 33% of adults recovering from COVID-19 still had problems one month to a year after being infected. A study suggested that long COVID symptoms are possible in vaccinated Americans.
- A study suggests faulty oxygen readings delayed COVID treatments for darker-skinned patients.
- A study found that dogs can detect positive COVID-19 cases. The research found that dogs identified 97% of positive cases after sniffing human sweat samples.
Centers for Disease Control and Prevention (CDC) Updates
The CDC published the following reports and website updates:
- COVID-19 Cases, Hospitalizations, and Deaths Among American Indian or Alaska Native Persons — Alaska, 2020–2021
- Cases in the U.S.
- Overall U.S. COVID-19 Vaccine Distribution and Administration Update as of Wed, 01 Jun 2022 06:00:00 EST
- V-safe After Vaccination Health Checker
- Frequently Asked Questions about v-safe
- Previous COVID-19 Forecasts: Hospitalizations
- Selected Adverse Events Reported after COVID-19 Vaccination
- COVID-19 Travel Recommendations by Country
- Requirement for Proof of COVID-19 Vaccination for Air Passengers
- Operational Guidance for K-12 Schools and Early Care and Education Programs to Support Safe In-Person Learning
- Frequently Asked Questions for Directors of Overnight Camps
- Clinical Care Considerations
- Reinfection
- Special Clinical Considerations
- Clinical Course: Progression, Management, and Treatment
- Diagnosis
- Clinical Presentation
- Interactive School Ventilation Tool
- Parents and Caregivers – What Is Your School Doing to Protect Your Child from COVID-19?
- Staffing Resources
- Schools and Childcare Programs
- Community, Work, and School
- Seizure- or Epilepsy-Related Emergency Department Visits Before and During the COVID-19 Pandemic — United States, 2019–2021
- Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021
- COVID Data Tracker Recent Updates – 2022-05-26 – The Vaccination Trends tab was updated to display trends in people 50 years and older receiving a second booster dose.
- COVID-19 Vaccination for Children and Teens with Disabilities
- Health Equity in Action
- Responder Stories
- COVID-19 Vaccine Recommendations for Children and Teens
- COVID-19 Vaccine Safety in Children and Teens
- Archive of COVID-19 Vaccination Data Updates
- Information About Johnson & Johnson’s Janssen COVID-19 Vaccine
- Frequently Asked Questions about COVID-19 Vaccination in Children
- Your COVID-19 Vaccination
- Information about the Moderna COVID-19 Vaccine
- Information about the Pfizer-BioNTech COVID-19 Vaccine
- Information for Health Departments on Reporting Cases of COVID-19
- Get Your COVID-19 Vaccine Booster Shot
- Stay Up to Date with Your Vaccines
- Protect Children and Teens from COVID-19
- COVID-19 Vaccine Booster Shot
- COVID-19 Vaccines for Moderately to Severely Immunocompromised People
- There are Different COVID-19 Vaccines
- What to Expect at Your Appointment to Get Vaccinated for COVID-19
- Frequently Asked Questions about COVID-19 Vaccination
- COVID-19 Vaccines for People Vaccinated Outside the United States
